KUST Q4 2025 Earnings Deep EPS Miss Highlights Operational Challenges Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting YORW Q1 2026 Earnings EPS Beats Estimates as Regulated Utility Shows Steady Performance BOXL Q1 2026 Earnings Significant EPS Beat Drives Positive Market Reaction BioTechne TECH Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher Kaltura Q1 2026 Earnings EPS Surges Past Estimates as Profitability Improves